CHOC’s multidisciplinary team provides integrative molecular diagnosis and customized treatment plans for children with brain and spine tumors.
Attacking pediatric brain tumors from both sides: A neurologist’s perspective
CHOC brings leading-edge initiatives to pediatric brain tumor treatment through a collaboration between neurology, neurosurgery and oncology.
New clinical trial uses immunotherapy to treat Diffuse Intrinsic Pontine Glioma (DIPG)
CHOC neuro-oncologist initiated a clinical trial to test a vaccine for DIPG, a rare and devastating cancer.
New mental health app supports pediatric cancer survivors
CHOC oncologists developed an app to promote inclusion and support pediatric cancer survivors facing mental health challenges.
Innovative protocol studies treatment for rare pediatric PTCL and NK/T-Cell lymphoma
CHOC helps develop innovative treatment protocols for PTCL and NK/T-cell lymphoma, which are now available for patients.
Virtual psychosocial support improves adolescent and young adult oncology outcomes during pandemic
When the pandemic hit, CHOC’s psychosocial programs for adolescents and young adults with cancer went virtual but brought new opportunities.
